US/UK/Canada

Share

About Us

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

Quotes

“The Free Online Memory Test allows individuals to take a scientifically-based assessment that can pinpoint potential problems with their cognitive functioning.
Mark Underwood, President Quincy Bioscience
Pick a time period -
Tags ( Active)

Neutricks® Study Results Presented at European College of Veterinary Behavioral Medicine

Madison, Wis (November 22, 2011) Quincy Animal Health, a leader in canine cognitive health, is pleased to announce, Dr. Gary Landsberg, DVM, a board certified veterinary behaviorist and diplomate of the American College of Veterinary Behaviorists, will be presenting research which demonstrates Neutricks®, an apoaequorin based supplement is able to significantly improve cognitive function in senior dogs. The research will be presented Sunday the 27thof November at the 2011 European Veterinary Behavior Meeting annual meeting held by both the European College of Veterinary Behavioral Medicine (

Neutricks® Study Results Presented at CanCog Conference on Behavior, Cognition and Aging in Companion Animals

Toronto, Canada -- (August 22, 2011) Quincy Animal Health, a leader in canine cognitive health, is excited to announce that Dr. Gary Landsberg, DVM, a board certified veterinary behaviorist and diplomate of the American College of Veterinary Behaviorists, presented data today which demonstrates Neutricks®, an apoaequorin based supplement is able to significantly improve cognitive function in senior dogs. The research was shared at the annual CanCog Conference on Behavior, Cognition and Aging in Companion Animals. Dr. Landsberg shared data from two different experiments showing the

Dogs Demonstrate Jellyfish Protein as a Potential Therapeutic for Memory Disorders at International Conference on Alzheimer’s Disease

Dogs Demonstrate Jellyfish Protein as a Potential Therapeutic for Memory Disorders at International Conference on Alzheimer’s Disease Paris, France -- (July 20, 2011) Quincy Animal Health, a leader in canine cognitive health, is pleased to announce that Quincy Animal Health President Mark Underwood presented data today which demonstrates an apoaequorin-containing chewable supplement is able to significantly improve cognitive function in senior dogs at the annual Alzheimer’s Association International Conference (AAIC) in Paris. Mr. Underwood presented data from two separate trials

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media